MAY 25, 2016 10:30 AM PDT

"Supercharging" Natural Killer Cells to Kill Cancer

WRITTEN BY: Kara Marker
Humans have specialized immune cells designed to detect and kill abnormal cells, whether they are virally-infected or cancerous cells. However, cancer cells can change to survive in their environment just like bacterial like Staphylococcus aureus evolve to have antibiotic resistance and scientists have to create a new influenza vaccine every year due to seasonal mutations. Likewise, cancer cells adapt to evade the immune cells, so researchers develop treatments to fight back, “supercharging” immune cells to avoid evasion.
 
For attacking cancerous cells, natural killer (NK) cells are the soldier of choice. NK cells identify and kill cancer cells as abnormal and then release chemicals that cause cell lysis. In a collaborative study between researchers from the Walter and Eliza Institute and Queensland Institute of Medical Research, scientists identified a way to reactivate NK cells that have been “silenced” by cancer cells.

NK cells require signals from an immune growth factor called interleukin (IL) 15. Interleukins are chemical messengers that communicate with dozens of immune cells, and IL-15 regulates the activation and proliferation of NK cells. However, NK cells contain an inhibitor that prevents them from adequately attacking cancer cells, rendering them unable to detect and kill cancerous cells before they divide and spread.
 
The current study, published in Nature Immunology, took an experimental model of metastatic melanoma to see if a drug that targeted the NK cell inhibitor would successfully reactivate NK cells to promote continuous, powerful cancer cell attacks. Metastatic melanoma is a late-stage cancer that described a state of cancer spread to the lymph nodes and “distant sites in the body and the body’s organs,” including the liver, lungs, bones, and brain.
 
In the experimental cancer model, removing the inhibitor did help NK cells target and kill cancer cells, and scientists are hopeful that a drug developed to do so could achieve the same result, and not just in cases of metastatic melanoma, but many other cancer types.
 

Sources: Walter and Eliza Hall Institute, Melanoma Research Foundation, National Center for Biotechnology Information, Centre d'Immunologie de Marseille-Luminy
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 08, 2020
Immunology
Scientists Use Genetics to Control Regulatory T Cells
JUL 08, 2020
Scientists Use Genetics to Control Regulatory T Cells
The ability to control regulatory T cells of the immune system has long been sought out by scientists, especially those ...
JUL 16, 2020
Immunology
Cancer Vaccine Charges Toward the Clinic
JUL 16, 2020
Cancer Vaccine Charges Toward the Clinic
Kristen Radford, a professor at Australia’s University of Queensland is among a scientific research team developin ...
JUL 21, 2020
Immunology
Hormone Therapies Keep Urinary Tract Infections at Bay
JUL 21, 2020
Hormone Therapies Keep Urinary Tract Infections at Bay
More than half of all women will suffer from a urinary tract infection, or UTI, during their lifetimes. Women are consid ...
AUG 25, 2020
Immunology
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
AUG 25, 2020
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
In a new study published in Cell, researchers have identified a metabolic enzyme that could have powerful tumor-killing ...
SEP 21, 2020
Immunology
The Perfect Storm: Wildfires, Flu and COVID-19
SEP 21, 2020
The Perfect Storm: Wildfires, Flu and COVID-19
Over 85 massive wildfires have swept through the West Coast, devastating communities in Washington, Oregon, and Californ ...
SEP 11, 2020
Immunology
Study Reveals Tumor Defense Mechanism... And How to Beat It
SEP 11, 2020
Study Reveals Tumor Defense Mechanism... And How to Beat It
  P53 is an infamous process gene at the core of the development of tumors.  When P53  functional, it pau ...
Loading Comments...